Last reviewed · How we verify

NCT07267637: ATBG

Autogenous Tooth Bone Graft for Alveolar Socket Preservation

Active, enrolled NA Last updated 5 December 2025
What this trial tests

NA trial testing "Autogenous Tooth Bone Graft" in Alveolar Bone Grafting in 20 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
14 July 2024
Primary endpoint
1 November 2025
31 August 2026

Quick facts

Lead sponsorHaifaa Mohammed Al-hussini
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date14 July 2024
Primary completion1 November 2025
Estimated completion31 August 2026
Sites1 location across Yemen

Drugs / interventions tested

Conditions studied

Sponsor

Haifaa Mohammed Al-hussini — full company profile →

Who can join

Adults 18 to 40, any sex, with Alveolar Bone Grafting or Bone Regeneration Following Wisdom Teeth Extraction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this clinical experiment is to assess how well autogenous tooth bone grafting preserves the alveolar socket after surgical tooth extraction. Before being inserted into the socket, the graft is made from the patient's own extracted tooth and ground into a particle. Twenty Yemeni patients who needed their teeth extracted are included in the trial, and they will be followed up with clinical and radiographic procedures using cone-beam computed tomography (CBCT) for six months. The primary objective is to ascertain whether the autogenous dental bone graft can preserve the height, width, and density of alveolar bone, offering a secure, affordable, and biocompatible substitute for traditional grafting materials.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Alveolar Bone Grafting

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07267637.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing